Efficient Drug Development
TNO works with public and private parties to create and implement innovative technologies that make the process of drug development – from laboratory to patient – more efficient. This will make it possible to cut development costs and to get drugs to patients sooner.
Our latest developments
9 resultaten, getoond 1 t/m 5
A preclinical model that captures the full complexity of CKM syndrome
CKM syndrome links heart, kidney and metabolism, but research often treats them separately. TNO’s new mouse model unites these systems for more relevant studies.
From lab to life in 24 Hours: i-screen demonstrates correlation between laboratory and human gut responses
Testing medicines outside the body: intestinal–liver–kidney model accelerates drug development
PPP uncovers new insights into MASLD development
Time setters: reduce long waits for new medication with AMS
Contact us
-
Steven Erpelinck
Functie:Principal Business Developer-
Standplaats:Leiden - Sylviusweg
-
Email:Email Steven
-
LinkedIn:Steven on LinkedIn
-
-
Martin Kirch
Functie:Director Health-
Standplaats:Leiden - Sylviusweg
-
Email:Email Martin
-